Abstract
Regulatory T-cells (Treg) represent a subset of CD4+ T-cells characterized by high suppressive capacity, which can be generated in the thymus or induced in the periphery. The deleterious phenotype of the Scurfy mouse, which develops an X-linked lymphoproliferative disease resulting from defective T-cell tolerance, clearly demonstrates the importance of Treg cells for the maintenance of immune homeostasis. Although significant progress has been achieved, much information regarding the development, characteristics and function of Treg cells remain lacking. This chapter highlights the most recent discoveries in the field of Treg biology, focusing on the development and role of this cell subset in the maintenance of immune balance.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adeegbe D, Matsutani T et al (2010) CD4(+) CD25(+) Foxp3(+) T regulatory cells with limited TCR diversity in control of autoimmunity. J Immunol 184(1):56–66
Akdis CA, Blaser K (2001) Mechanisms of interleukin-10-mediated immune suppression. Immunology 103(2):131–136
Allan SE, Crome SQ et al (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19(4):345–354
Apostolou I, von Boehmer H (2004) In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199(10):1401–1408
Arpaia NC, Campbell et al. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 7480:451–455
Atarashi K, Tanoue T et al (2011) Induction of colonic regulatory T-cells by indigenous Clostridium species. Science 331(6015):337–341
Atarashi K, Tanoue T et al (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500(7461):232–236
Bacchetta R, Lucarelli B et al (2014) Immunological Outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T Cells. Front Immunol 5:16
Bagavant H, Tung KS (2005) Failure of CD25+ T-cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis. J Immunol 175(2):944–950
Banerjee A, Vasanthakumar A et al (2013) Modulating T regulatory cells in cancer: how close are we? Immunol Cell Biol 91(5):340–349
Barath S, Aleksza M et al (2007) Measurement of natural (CD4+ CD25high) and inducible (CD4+ IL-10+) regulatory T-cells in patients with systemic lupus erythematosus. Lupus 16(7):489–496
Barnes MJ, Krebs P et al (2009) Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol 7(3):e51
Baron U, Floess S et al (2007) DNA demethylation in the human FOXP3 locus discriminates regulatory T-cells from activated FOXP3(+) conventional T cells. Eur J Immunol 37(9):2378–2389
Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215–233
Battaglia M, Stabilini A et al (2006) Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T-cells of both healthy subjects and type 1 diabetic patients. J Immunol 177(12):8338–8347
Bazhin AV, Kahnert S et al (2010) Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells. Mol Immunol 47(4):678–684
Bedner P, Niessen H et al (2006) Selective permeability of different connexin channels to the second messenger cyclic AMP. J Biol Chem 281(10):6673–6681
Beebe AM, Cua DJ et al (2002) The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13(4–5):403–412
Bennett CL, Christie J et al (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27(1):20–21
Bettelli E, Das MP et al (1998) IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161(7):3299–3306
Bilate AM, Lafaille JJ (2012) Induced CD4+Foxp3+ regulatory T-cells in immune tolerance. Annu Rev Immunol 30:733–758
Bodor J, Feigenbaum L et al (2001) Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER). J Leukoc Biol 69(6):1053–1059
Bopp T, Becker C et al (2007) Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204(6):1303–1310
Brunstein CG, Miller JS et al (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117(3):1061–1070
Brusko T, Wasserfall C et al (2007) No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56(3):604–612
Burzyn D, Benoist C et al (2013) Regulatory T-cells in nonlymphoid tissues. Nat Immunol 14(10):1007–1013
Burzyn D, Kuswanto W et al (2013) A special population of regulatory T-cells potentiates muscle repair. Cell 155(6):1282–1295
Cebula A, Seweryn M et al (2013) Thymus-derived regulatory T-cells contribute to tolerance to commensal microbiota. Nature 497(7448):258–262
Chambers CA, Kuhns MS et al (2001) CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 19:565–594
Chatila TA, Blaeser F et al (2000) JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106(12):R75–R81
Chaudhry A, Rudra D et al (2009) CD4+ regulatory T-cells control TH17 responses in a Stat3-dependent manner. Science 326(5955):986–991
Chen W, Jin W et al (2003) Conversion of peripheral CD4+CD25− naive T-cells to CD4+CD25+ regulatory T-cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198(12):1875–1886
Cho JH, Gregersen PK (2011) Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365(17):1612–1623
Chong MM, Rasmussen JP et al (2008) The RNAseIII enzyme Drosha is critical in T-cells for preventing lethal inflammatory disease. J Exp Med 205(9):2005–2017
Chung Y, Tanaka S et al (2011) Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 17(8):983–988
Cipolletta D, Feuerer M et al (2012) PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486(7404):549–553
Collison LW, Workman CJ et al (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566–569
Collison LW, Chaturvedi V et al (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11(12):1093–1101
Crispin JC, Liossis SN et al (2010) Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 16(2):47–57
Curiel TJ, Coukos G et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942–949
Curotto de Lafaille MA, Lino AC et al (2004) CD25− T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol 173(12):7259–7268
Curotto de Lafaille MA, Kutchukhidze N et al (2008) Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29(1):114–126
Curti A, Pandolfi S et al (2007) Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25− into CD25+ T regulatory cells. Blood 109(7):2871–2877
Datto MB, Frederick JP et al (1999) Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol 19(4):2495–2504
Deaglio S, Dwyer KM et al (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204(6):1257–1265
Demir L, Yigit S et al (2013) Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clin Exp Metastasis 30(8):1047–1062
Di Ianni M, Falzetti F et al (2011) Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117(14):3921–3928
Duhen T, Duhen R et al (2012) Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 119(19):4430–4440
Elkord E (2009) Frequency of human T regulatory cells in peripheral blood is significantly reduced by cryopreservation. J Immunol Methods 347(1–2):87–90
Etemire E, Krull M et al (2013) Transiently reduced PI3 K/Akt activity drives the development of regulatory function in antigen-stimulated Naive T-cells. PLoS ONE 8(7):e68378
Fallarino F, Grohmann U et al (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176(11):6752–6761
Fantini MC, Becker C et al (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25− T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172(9):5149–5153
Feuerer M, Herrero L et al (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15(8):930–939
Feuerer M, Hill JA et al (2009) Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 10(7):689–695
Floess S, Freyer J et al (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5(2):e38
Fohse L, Suffner J et al (2011) High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells. Eur J Immunol 41(11):3101–3113
Fontenot JD, Gavin MA et al (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4(4):330–336
Fontenot JD, Rasmussen JP et al (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6(11):1142–1151
Friedlander MR, Lizano E et al (2014) Evidence for the biogenesis of more than 1,000 novel human microRNAs. Genome Biol 15(4):R57
Furtado GC, Curotto de Lafaille MA et al (2002) Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 196(6):851–857
Furusawa Y, Obata Y et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446–450
Gagliani N, Magnani CF et al (2013) Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 19(6):739–746
Gavin MA, Torgerson TR et al (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 103(17):6659–6664
Gazzinelli RT, Wysocka M et al (1996) In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157(2):798–805
Glisic-Milosavljevic S, Waukau J et al (2007) At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction. PLoS ONE 2(1):e146
Gobert M, Treilleux I et al (2009) Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 69(5):2000–2009
Goerner M, Gooley T et al (2002) Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biol Blood Marrow Transplant 8(1):47–56
Gottschalk RA, Corse E et al (2010) TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med 207(8):1701–1711
Govindaraj C, Scalzo-Inguanti K et al (2013) Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment. Clin Immunol 149(1):97–110
Grohmann U, Fallarino F et al (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 24(5):242–248
Grohmann U, Volpi C et al (2007) Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 13(5):579–586
Groux H, O’Garra A et al (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389(6652):737–742
Guo H, Ingolia NT et al (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308):835–840
Gupta S, Manicassamy S et al (2008) Differential requirement of PKC-theta in the development and function of natural regulatory T cells. Mol Immunol 46(2):213–224
Hata H, Sakaguchi N et al (2004) Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114(4):582–588
Hayashi T, Hasegawa K et al (2005) Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB × NZW F mice. Int J Exp Pathol 86(5):289–296
Herman AE, Freeman GJ et al (2004) CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 199(11):1479–1489
Hindley JP, Ferreira C et al (2011) Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors. Cancer Res 71(3):736–746
Hinterberger M, Aichinger M et al (2010) Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance. Nat Immunol 11(6):512–519
Hoffmann P, Boeld TJ et al (2006) Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant 12(3):267–274
Hori S, Haury M et al (2002) Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 99(12):8213–8218
Hori S, Nomura T et al (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057–1061
Hsieh CS, Liang Y et al (2004) Recognition of the peripheral self by naturally arising CD25+CD4+ T cell receptors. Immunity 21(2):267–277
Hsu WT, Suen JL et al (2006) The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin Exp Immunol 145(3):513–519
Hsu LY, Tan YX et al (2009) A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity. J Exp Med 206(11):2527–2541
Hung T, Wang Y et al (2011) Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 43(7):621–629
Isomura I, Palmer S et al (2009) c-Rel is required for the development of thymic Foxp3+CD4 regulatory T cells. J Exp Med 206(13):3001–3014
Itoh M, Takahashi T et al (1999) Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162(9):5317–5326
Jailwala P, Waukau J et al (2009) Apoptosis of CD4+CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation. PLoS ONE 4(8):e6527
Jordan MS, Boesteanu A et al (2001) Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2(4):301–306
Kerdiles YM, Stone EL et al (2010) Foxo transcription factors control regulatory T cell development and function. Immunity 33(6):890–904
Khalil AM, Guttman M et al (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106(28):11667–11672
Khattri R, Cox T et al (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4(4):337–342
Kim HP, Leonard WJ (2007) CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 204(7):1543–1551
Kim JM, Rasmussen JP et al (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8(2):191–197
Kitani A, Fuss I et al (2003) Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J Exp Med 198(8):1179–1188
Koch MA, Tucker-Heard G et al (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10(6):595–602
Koonpaew S, Shen S et al (2006) LAT-mediated signaling in CD4+CD25+ regulatory T cell development. J Exp Med 203(1):119–129
Kornete M, Sgouroudis E et al (2012) ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J Immunol 188(3):1064–1074
Kretschmer K, Apostolou I et al (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6(12):1219–1227
Ladoire S, Martin F et al (2011) Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 60(7):909–918
Lahl K, Loddenkemper C et al (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204(1):57–63
Lathrop SK, Bloom SM et al (2011) Peripheral education of the immune system by colonic commensal microbiota. Nature 478(7368):250–254
Laurie KL, Van Driel IR et al (2002) The role of CD4+CD25+ immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol 80(6):567–573
Leon LR, Kozak W et al (1998) Role of IL-10 in inflammation. Studies using cytokine knockout mice. Ann N Y Acad Sci 856:69–75
Liao G, Nayak S et al (2010) GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells. Int Immunol 22(4):259–270
Lin SC, Chen KH et al (2007) The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 37(12):987–996
Lin SZ, Chen KJ et al (2013) Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Cancer Prev Res (Phila) 6(6):594–602
Linterman MA, Pierson W et al (2011) Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med 17(8):975–982
Lio CW, Dodson LF et al (2010) CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors. J Immunol 184(11):6007–6013
Liston A, Lu LF et al (2008) Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205(9):1993–2004
Liu W, Putnam AL et al (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203(7):1701–1711
Liu VC, Wong LY et al (2007) Tumor evasion of the immune system by converting CD4+CD25− T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol 178(5):2883–2892
Liu X, Robinson SN et al (2014) FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells. Bone Marrow Transplant 49(6):793–799
Loewer S, Cabili MN et al (2010) Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 42(12):1113–1117
Lu LF, Thai TH et al (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30(1):80–91
Lu LF, Boldin MP et al (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142(6):914–929
Lu L, Ma J et al (2011) All-trans retinoic acid promotes TGF-beta-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus. PLoS ONE 6(9):e24590
Lyssuk EY, Torgashina AV et al (2007) Reduced number and function of CD4+CD25 high FoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 601:113–119
Macfarlane GT, Macfarlane S (1997) Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 222:3–9
Makita S, Kanai T et al (2007) Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation. J Immunol 178(8):4937–4946
Mantel PY, Ouaked N et al (2006) Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 176(6):3593–3602
Marek-Trzonkowska N, Mysliwiec M et al (2012) Administration of CD4+CD25 high CD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care 35(9):1817–1820
Marks SD, Tullus K (2012) Autoantibodies in systemic lupus erythematosus. Pediatr Nephrol 27(10):1855–1868
Marson A, Kretschmer K et al (2007) Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445(7130):931–935
McHugh RS, Whitters MJ et al (2002) CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16(2):311–323
Mestecky J, McGhee JR (1987) Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40:153–245
Miyara M, Amoura Z et al (2005) Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175(12):8392–8400
Miyara M, Yoshioka Y et al (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30(6):899–911
Mucida D, Kutchukhidze N et al (2005) Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115(7):1923–1933
Nakamura K, Kitani A et al (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194(5):629–644
Nakamura K, Kitani A et al (2004) TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172(2):834–842
Nelson BH, Willerford DM (1998) Biology of the interleukin-2 receptor. Adv Immunol 70:1–81
Nguyen LT, Jacobs J et al (2007) Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 56(2):509–520
Ohkura N, Hamaguchi M et al (2012) T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37(5):785–799
Olivares-Villagomez D, Wang Y et al (1998) Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 188(10):1883–1894
Onishi Y, Fehervari Z et al (2008) Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA 105(29):10113–10118
Onizuka S, Tawara I et al (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59(13):3128–3133
Ostman S, Rask C et al (2006) Impaired regulatory T cell function in germ-free mice. Eur J Immunol 36(9):2336–2346
Ouyang W, Beckett O et al (2010) Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 11(7):618–627
Ouyang W, Liao W et al (2012) Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491(7425):554–559
Pacholczyk R, Kern J (2008) The T-cell receptor repertoire of regulatory T cells. Immunology 125(4):450–458
Pacholczyk R, Ignatowicz H et al (2006) Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 25(2):249–259
Pandiyan P, Zheng L et al (2007) CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 8(12):1353–1362
Pandiyan P, Conti HR et al (2011) CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34(3):422–434
Papiernik M (2001) Natural CD4+CD25+ regulatory T cells. Their role in the control of superantigen responses. Immunol Rev 182:180–189
Park HJ, Kusnadi A et al (2012) Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors. Cell Immunol 278(1–2):76–83
Patterson SJ, Han JM et al (2011) Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. J Immunol 186(10):5533–5537
Patton DT, Garden OA et al (2006) Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 177(10):6598–6602
Peters JH, Preijers FW et al (2008) Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation. PLoS ONE 3(9):e3161
Putnam AL, Vendrame F et al (2005) CD4+CD25 high regulatory T cells in human autoimmune diabetes. J Autoimmun 24(1):55–62
Qiao YQ, Huang ML et al (2013) LncRNA DQ786243 affects Treg related CREB and Foxp3 expression in Crohn’s disease. J Biomed Sci 20:87
Qin J, Li R et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59–65
Racke MK, Burnett D et al (1995) Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154(1):450–458
Rao S, Gerondakis S et al (2003) c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J Immunol 170(7):3724–3731
Read S, Greenwald R et al (2006) Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol 177(7):4376–4383
Ronchetti S, Zollo O et al (2004) GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 34(3):613–622
Rouas R, Fayyad-Kazan H et al (2009) Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 39(6):1608–1618
Ruan Q, Kameswaran V et al (2009) Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 31(6):932–940
Rubtsov YP, Rasmussen JP et al (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28(4):546–558
Rudra D, deRoos P et al (2012) Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol 13(10):1010–1019
Sadlack B, Kuhn R et al (1994) Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur J Immunol 24(1):281–284
Sadlack B, Lohler J et al (1995) Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 25(11):3053–3059
Salomon B, Lenschow DJ et al (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12(4):431–440
Samstein RM, Arvey A et al (2012) Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151(1):153–166
Samstein RM, Josefowicz SZ et al (2012) Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150(1):29–38
Saoudi A, Seddon B et al (1996) The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol Rev 149:195–216
Sather BD, Treuting P et al (2007) Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 204(6):1335–1347
Sattui S, de la Flor C et al (2012) Cryopreservation modulates the detection of regulatory T cell markers. Cytometry B Clin Cytom 82(1):54–58
Savage PA, Malchow S et al (2013) Basic principles of tumor-associated regulatory T cell biology. Trends Immunol 34(1):33–40
Scalapino KJ, Tang Q et al (2006) Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 177(3):1451–1459
Schmidl C, Klug M et al (2009) Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res 19(7):1165–1174
Schmidt AM, Zou T et al (2013) Diacylglycerol kinase zeta limits the generation of natural regulatory T cells. Sci Signal 6(303):ra101
Schmidt-Supprian M, Courtois G et al (2003) Mature T cells depend on signaling through the IKK complex. Immunity 19(3):377–389
Seale AC, de Jong BC et al (2008) Effects of cryopreservation on CD4+CD25+ T cells of HIV-1 infected individuals. J Clin Lab Anal 22(3):153–158
Sell K, Barth PJ et al (2012) Localization of FOXP3-positive cells in renal cell carcinoma. Tumour Biol 33(2):507–513
Shevach EM, Stephens GL (2006) The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 6(8):613–618
Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113(6):685–700
Shimizu J, Yamazaki S et al (2002) Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3(2):135–142
Siggs OM, Miosge LA et al (2007) Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 27(6):912–926
Sledzinska A, Hemmers S et al (2013) TGF-beta Signalling Is Required for CD4(+) T Cell Homeostasis But Dispensable for Regulatory T Cell Function. PLoS Biol 11(10):e1001674
Sobel ES, Brusko TM et al (2011) Defective response of CD4(+) T cells to retinoic acid and TGFbeta in systemic lupus erythematosus. Arthritis Res Ther 13(3):R106
Somerset DA, Zheng Y et al (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+CD4+ regulatory T-cell subset. Immunology 112(1):38–43
Stephens GL, McHugh RS et al (2004) Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 173(8):5008–5020
Suen JL, Li HT et al (2009) Altered homeostasis of CD4(+)FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 127(2):196–205
Suffia IJ, Reckling SK et al (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 203(3):777–788
Szymczak-Workman AL, Delgoffe GM et al (2011) Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathways. J Immunol 187(9):4416–4420
Tai X, Cowan M et al (2005) CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6(2):152–162
Takahashi T, Tagami T et al (2000) Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192(2):303–310
Tanchot C, Terme M et al (2013) Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance. Cancer Microenviron 6(2):147–157
Teles A, Schumacher A et al (2013) Control of uterine microenvironment by foxp3(+) cells facilitates embryo implantation. Front Immunol 4:158
Tivol EA, Borriello F et al (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3(5):541–547
Tran DQ, Ramsey H et al (2007) Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110(8):2983–2990
Trzonkowski P, Bieniaszewska M et al (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells. Clin Immunol 133(1):22–26
Turner M, Galloway A et al (2014) Noncoding RNA and its associated proteins as regulatory elements of the immune system. Nat Immunol 15(6):484–491
Valencia X, Yarboro C et al (2007) Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178(4):2579–2588
Valzasina B, Piconese S et al (2006) Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25− lymphocytes is thymus and proliferation independent. Cancer Res 66(8):4488–4495
van Santen HM, Benoist C et al (2004) Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med 200(10):1221–1230
Vargas-Rojas MI, Crispin JC et al (2008) Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 17(4):289–294
Venigalla RK, Tretter T et al (2008) Reduced CD4+,CD25− T cell sensitivity to the suppressive function of CD4+,CD25 high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 58(7):2120–2130
Viguier M, Lemaitre F et al (2004) Foxp3 expressing CD4+CD25 (high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173(2):1444–1453
Wainwright DA, Dey M et al (2013) Targeting tregs in malignant brain cancer: overcoming IDO. Front Immunol 4:116
Wan YY, Flavell RA (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci USA 102(14):5126–5131
Wan YY, Chi H et al (2006) The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol 7(8):851–858
Wang J, Huizinga TW et al (2009) De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid. J Immunol 183(6):4119–4126
Wang KC, Yang YW et al (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472(7341):120–124
Wei G, Wei L et al (2009) Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30(1):155–167
Weiss JM, Bilate AM et al (2012) Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med 209(10):1723–1742, S1721
Whiteside TL (2012) What are regulatory T cells (Treg) regulating in cancer and why? Semin Cancer Biol 22(4):327–334
Wildin RS, Freitas A (2005) IPEX and FOXP3: clinical and research perspectives. J Autoimmun 25(Suppl):56–62
Wildin RS, Ramsdell F et al (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27(1):18–20
Wing K, Onishi Y et al (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322(5899):271–275
Wong J, Obst R et al (2007) Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells. J Immunol 178(11):7032–7041
Xufre C, Costa M et al (2013) Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients. Int Immunol 25(10):563–574
Yadav M, Louvet C et al (2012) Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 209(10):1713–1722, S1711–1719
Yadav M, Stephan S et al (2013) Peripherally induced tregs—role in immune homeostasis and autoimmunity. Front Immunol 4:232
Yan B, Ye S et al (2008) Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum 58(3):801–812
Yang W, Xu Y (2013) Clinical significance of Treg cell frequency in acute myeloid leukemia. Int J Hematol 98(5):558–562
Yang ZZ, Novak AJ et al (2006) Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107(9):3639–3646
Yates J, Whittington A et al (2008) Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol 153(1):44–55
Zhan Y, Funda DP et al (2004) TCR-mediated activation promotes GITR upregulation in T cells and resistance to glucocorticoid-induced death. Int Immunol 16(9):1315–1321
Zhao SS, Li XM et al (2008) Expression of CD4+CD25+CD127(low/-) T cells in patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi 88(7):453–456
Zheng SG, Gray JD et al (2002) Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25− precursors. J Immunol 169(8):4183–4189
Zheng SG, Wang JH et al (2006) TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol 176(6):3321–3329
Zheng SG, Wang J et al (2007) IL-2 is essential for TGF-beta to convert naive CD4+CD25− cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178(4):2018–2027
Zheng Y, Josefowicz SZ et al (2007) Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445(7130):936–940
Zheng Y, Chaudhry A et al (2009) Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458(7236):351–356
Zheng Y, Josefowicz S et al (2010) Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463(7282):808–812
Zhou G, Levitsky HI (2007) Natural regulatory T-cells and de novo-induced regulatory T-cells contribute independently to tumor-specific tolerance. J Immunol 178(4):2155–2162
Zhou X, Bailey-Bucktrout SL et al (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T-cells in vivo. Nat Immunol 10(9):1000–1007
Zunino SJ, Storms DH et al (2007) Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice. J Nutr 137(5):1216–1221
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Piccioni, M., Chen, Z., Tsun, A., Li, B. (2014). Regulatory T-Cell Differentiation and Their Function in Immune Regulation. In: Sun, B. (eds) T Helper Cell Differentiation and Their Function. Advances in Experimental Medicine and Biology, vol 841. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9487-9_4
Download citation
DOI: https://doi.org/10.1007/978-94-017-9487-9_4
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9486-2
Online ISBN: 978-94-017-9487-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)